Cases & Deals

  • Home
  • Practices
  • CARMAT completes €40.5 million share capital increase

Share

CARMAT completes €40.5 million share capital increase

April 2022

Client(s) CARMAT SA

Jones Day represented CARMAT SA, the designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative to people suffering from end-stage biventricular heart failure, with its €40.5 million share capital increase, of which €36.5 million is aimed at specialized and strategic investors and €4.1 million for individuals (via the PrimaryBid platform).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.